<?xml version="1.0" encoding="UTF-8"?>
<article>
  <antidek></antidek>
  <author></author>
  <body>&amp;nbsp;
&lt;table&gt;&lt;tr&gt;&lt;TD valign="top"&gt;

&lt;div class="articleImg" style="width: 210px"&gt;&lt;img src="/statics/BB21409JosephListerHR_a_v_sm.jpg" alt="Joseph Lister" /&gt;&lt;p class="credit"&gt;Brown Brothers&lt;/p&gt;&lt;/div&gt;

&lt;/td&gt;&lt;TD valign="top"&gt;

&lt;h3&gt;1867 &lt;/h3&gt;&lt;p&gt;English surgeon Joseph Lister describes his use of carbolic acid as an antiseptic during surgery, eradicating microbes and preventing infection. &lt;/p&gt;

&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table&gt;&lt;tr&gt;&lt;TD valign="top"&gt;

&lt;/td&gt;&lt;TD valign="top"&gt;

&lt;h3&gt;1876 &lt;/h3&gt;&lt;p&gt;
German physician Robert Koch publishes work proving that bacteria cause disease, with anthrax bacilli as Exhibit A; Koch&amp;rsquo;s four postulates for determining the cause of new microbial diseases are still used today. &lt;/p&gt;

&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table&gt;&lt;tr&gt;&lt;TD valign="top"&gt;

&lt;div class="articleImg" style="width: 200px"&gt;&lt;img src="/statics/corb_PG7799_a_sq_sm.jpg" alt="Alexander Fleming" /&gt;&lt;p class="credit"&gt;Bettmann/Corbis&lt;/p&gt;&lt;/div&gt;

&lt;/td&gt;&lt;TD valign="top"&gt;

&lt;h3&gt;1928 &lt;/h3&gt;&lt;p&gt;
Scottish biologist Alexander Fleming finds that a &lt;i&gt;Penicillium notatum&lt;/i&gt; mold growing on a lab plate full of &lt;i&gt;Staphylococcus&lt;/i&gt; kills the bacteria around it. He names the active substance penicillin, but because it&amp;rsquo;s so difficult to purify large amounts, he drops the research.&lt;/p&gt;

&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;h3&gt;1932 &lt;/h3&gt;&lt;p&gt;
In a lab at Bayer in Germany, Gerhard Domagk discovers that a sulfa drug, later called Prontosil, defeats streptococci in mice and is later found to work in humans.&lt;/p&gt;

&lt;table&gt;&lt;tr&gt;&lt;TD valign="top"&gt;

&lt;div class="articleImg" style="width: 200px"&gt;&lt;img src="/statics/F_08_phototake004706E00001003_a_sq_sm.jpg" alt="Penicillin" /&gt;&lt;p class="credit"&gt;Dennis Kunkel/Phototake&lt;/p&gt;&lt;/div&gt;

&lt;/td&gt;&lt;TD valign="top"&gt;

&lt;h3&gt;1939 &lt;/h3&gt;&lt;p&gt;
French microbiologist Rene Dubos discovers gramicidin in soil, ultimately the primary source of many antibiotics; Oxford scientists Howard Florey and Ernst Chain figure out how to produce substantial quantities of penicillin, leading to its industrial production.&lt;/p&gt;

&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table&gt;&lt;tr&gt;&lt;TD valign="top"&gt;

&lt;div class="articleImg" style="width: 200px"&gt;&lt;img src="/statics/corb_42-19126712_a_ss.jpg" alt="Antibiotics" /&gt;&lt;p class="credit"&gt;Frans Lanting/Corbis&lt;/p&gt;&lt;/div&gt;

&lt;/td&gt;&lt;TD valign="top"&gt;

&lt;h3&gt;1944-68 &lt;/h3&gt;&lt;p&gt;
Most major classes of antibiotics, including the aminoglycosides, cephalosporins and tetracyclines, are introduced.&lt;/p&gt;

&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;h3&gt;2000 &lt;/h3&gt;&lt;p&gt;
After a number of years, the FDA approves a new class of antibiotics, oxazolidinones, for clinical use.&lt;/p&gt; 

&lt;h3&gt;2003 &lt;/h3&gt;&lt;p&gt;
The FDA approves a second new class of antibiotics, lipopeptides.&lt;/p&gt;

&lt;h3&gt;2007 &lt;/h3&gt;&lt;p&gt;
With antibiotic resistance on the rise, the &lt;a href="http://www.govtrack.us/congress/bill.xpd?bill=h110-3697" target="_blank"&gt;Strategies to Address Antimicrobial Resistance&lt;/a&gt; (STAAR) Act is introduced in Congress. &lt;/p&gt;

&lt;table&gt;&lt;tr&gt;&lt;TD valign="top"&gt;

&lt;div class="articleImg" style="width: 200px"&gt;&lt;img src="/statics/veer_RF_DVP4973702_a_ss.jpg" alt="The Senate Committee on Health, Education, Labor and Pensions" /&gt;&lt;p class="credit"&gt;Digital Vision Photography/Veer&lt;/p&gt;&lt;/div&gt;

&lt;/td&gt;&lt;TD valign="top"&gt;

&lt;h3&gt;2008 &lt;/h3&gt;&lt;p&gt;
The Senate Committee on Health, Education, Labor, and Pensions considers incentives such as federal grants, tax credits and data exclusivity protection to encourage pharmaceutical companies to develop new antibiotics.&lt;/p&gt;

&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
</body>
  <body-2-headline>The War on Superbugs</body-2-headline>
  <body-2-image-id type="integer">175</body-2-image-id>
  <body-text-2>&lt;p&gt;As medicine battles antibiotic resistance, tougher drugs breed still more deadly bacteria. New approaches could break the cycle. &lt;/p&gt;

&lt;div class="articleLink"&gt;

&lt;span&gt;// &lt;/span&gt;

&lt;a href="/assets/the-rise-and-fall-of-antibiotics"&gt;MORE&lt;/a&gt;

&lt;/div&gt;

&lt;br /&gt;

 

&lt;h2&gt;Out With the Big, In with the Little &lt;/h2&gt;

 

&lt;p&gt;Small biotechs are picking up antibiotic research where Big Pharma left off. Will their efforts be enough to beat resistance?&lt;/p&gt;

 

 

&lt;div class="articleLink"&gt;

&lt;span&gt;// &lt;/span&gt;

&lt;a href="/assets/out-with-the-big-in-with-the-little"&gt;MORE&lt;/a&gt;

&lt;/div&gt;</body-text-2>
  <body-text-3></body-text-3>
  <channel-image-id type="integer">0</channel-image-id>
  <created-at type="datetime">2008-10-27T17:34:59-05:00</created-at>
  <created-by type="integer">#&lt;User:0xa346688&gt;</created-by>
  <deck>They started out packing a punch, but antibiotics are not invincible. </deck>
  <downloadable-static-id type="integer">0</downloadable-static-id>
  <expire-at type="datetime" nil="true"></expire-at>
  <headline>The Rise and Fall of Antibiotics </headline>
  <homepage-image-id type="integer">0</homepage-image-id>
  <id type="integer">64</id>
  <infographic-id type="integer" nil="true"></infographic-id>
  <is-active type="boolean">false</is-active>
  <issue>Fall 2008</issue>
  <language nil="true"></language>
  <lead-headline>The Rise and Fall of Antibiotics </lead-headline>
  <lead-subheadline></lead-subheadline>
  <live-at type="datetime" nil="true"></live-at>
  <meta-description>They started out packing a punch, but antibiotics are not invincible.</meta-description>
  <meta-keywords>antibiotics, bacteria, penicillin,  cephalosporins, aminoglycosides, tetracyclines, oxazolidinones, lipopeptides, joseph lister, antiseptic, robert koch, anthrax, alexander fleming, penicillin, staph, rene dubos, gramicidin, strategies to addres antimicro</meta-keywords>
  <parent-id type="integer" nil="true"></parent-id>
  <permalink>the-rise-and-fall-of-antibiotics</permalink>
  <photo-credit nil="true"></photo-credit>
  <photo-gallery-id type="integer" nil="true"></photo-gallery-id>
  <publish-date type="date">2008-09-01</publish-date>
  <related-asset-1-id type="integer">57</related-asset-1-id>
  <related-asset-2-id type="integer">65</related-asset-2-id>
  <related-asset-3-id type="integer" nil="true"></related-asset-3-id>
  <rightrail-image-id type="integer" nil="true"></rightrail-image-id>
  <static-id type="integer">0</static-id>
  <summary>They started out packing a punch, but antibiotics are not invincible. </summary>
  <thumbnail-id type="integer">207</thumbnail-id>
  <title>The Rise and Fall of Antibiotics </title>
  <updated-at type="datetime">2008-12-11T13:05:43-06:00</updated-at>
  <updated-by type="integer">#&lt;User:0xa343cf8&gt;</updated-by>
</article>
